CAP Review and Forecast: Advocacy 2024/2025

Throughout 2024, the College of American Pathologists (CAP) advocated on behalf of pathologists to address critical issues, including the oversight of laboratory-developed tests (LDTs), protecting the value of pathology services, opposing private payer interference, and state-level regulation of health insurance. The CAP is now ready to engage on these and other important pathology issues during the first 100 days of the Trump Administration and new Congress in 2025. In this special episode, Council on Government and Professional Affairs Chair Joe Saad, MD, CPE, FCAP highlights a year of advocacy legislative wins and 2025 legislative priorities.Advocacy highlights in this episode:CAP President testifies during congressional hearing on LDT oversight, CAP NewsroomCapitol Hill briefing on LDTs, YouTubeLetter to Trump Transition Team about rescinding the LDT final rule (PDF)Letter to Office for Management & Budget opposing the LDT final rule (PDF)Pathologists meet with Congress to oppose Medicare cuts, CAP Advocacy UpdateStudy examining the adverse impact of insurance interference (PDF)Illinois pathologists and CAP secure new network adequacy law, CAP Advocacy Update